US Broker Ratings

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 17.54% Potential Upside with Analyst Ratings in Focus

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector, operates as a medical device company with a robust portfolio of orthopedic reconstructive products. With a market..

BioNTech SE (BNTX) Stock Analysis: Navigating a 28% Potential Upside with Strategic Investments in Immunotherapy

BioNTech SE (NASDAQ: BNTX), the German biotechnology powerhouse, has been a focal point for investors aiming to capitalize on advancements in cancer and infectious disease therapies. As of now, the..

Revvity, Inc. (RVTY) Stock Analysis: Unpacking a 27% Potential Upside in Healthcare Diagnostics

Revvity, Inc. (NYSE: RVTY), a stalwart in the healthcare diagnostics and research industry, presents a compelling opportunity for investors seeking exposure to the life sciences sector. With a market capitalization..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 21% Potential Upside for Investors

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans sector, is making waves in the investment community with its robust growth metrics and potential upside, currently pegged..

Cencora, Inc. (COR) Stock Analysis: Exploring a Robust 7.37% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare sector, has been making waves in the medical distribution industry. With a solid market cap of $58.03 billion, the company..

Alcon Inc. (ALC) Stock Analysis: Unveiling a 20.48% Upside Potential for Investors

Alcon Inc. (NYSE: ALC), a leader in the global eye care industry, is making waves in the healthcare sector with its robust portfolio of innovative products and promising growth potential...

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 17% Potential Upside Beckons Investors

GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a formidable player within the healthcare sector, specifically focusing on health information services. With a market capitalization of $34.06 billion, this U.S.-based..

Illumina, Inc. (ILMN) Stock Analysis: Unveiling a 14.87% Potential Upside Amidst Market Challenges

Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector, is renowned for its cutting-edge genomic and genetic sequencing solutions. Headquartered in San Diego, California, Illumina plays a pivotal role..

argenx SE (ARGX) Stock Analysis: Unveiling a 38.75% Potential Upside Fueled by Breakthrough Biotech Innovations

argenx SE (NASDAQ: ARGX), a pioneering name in the biotechnology sector, is capturing the attention of investors with its robust growth trajectory and promising drug pipeline. Based in the Netherlands,..

Insulet Corporation (PODD) Stock Analysis: A Look at its Robust Revenue Growth and Analyst Optimism

Insulet Corporation (NASDAQ: PODD), a pioneer in the medical devices sector, is making waves with its innovative insulin delivery systems. As a leader in healthcare technology, Insulet has captured investor..

Koninklijke Philips N.V. (PHG) Investor Outlook: Exploring a 31.59% Upside Potential in the Healthcare Sector

As an integral player in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) has piqued investor interest with its robust presence in the medical devices industry. Headquartered in Amsterdam, the..

Encompass Health Corporation (EHC) Stock Analysis: A Lucrative Healthcare Play with Solid Growth Prospects

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, presents a compelling opportunity for investors looking to tap into the medical care facilities industry. With a market..

Stryker Corporation (SYK) Stock Analysis: Exploring a 7% Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK), a leading player in the healthcare sector, is catching the eye of investors with its robust market presence and growth potential. Operating within the medical devices..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Biotech Giant with a $42 Billion Market Cap and Promising Pipeline

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering force in the biotechnology sector, has carved a niche for itself through its groundbreaking work in ribonucleic acid interference (RNAi) therapeutics. With a..

Waters Corporation (WAT) Stock Analysis: A 10.32% Potential Upside with Strong Analyst Confidence

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, is capturing investor attention with a market capitalization of $20.97 billion. The..

Astrazeneca PLC (AZN)

⚠️ No article content returned.

..

Medtronic plc (MDT): Investor Outlook and Potential 11.71% Upside in the Healthcare Sector

Medtronic plc (MDT), a global leader in the medical devices industry, offers a compelling investment opportunity with a potential upside of 11.71%, according to analyst ratings. Headquartered in Galway, Ireland,..

Sanofi (SNY)

⚠️ No article content returned.

..

Royalty Pharma plc (RPRX) Stock Analysis: A Promising 15.76% Potential Upside for Investors

Royalty Pharma plc (NASDAQ: RPRX), a leader in the biotechnology sector, is capturing investor attention with a notable potential upside of 15.76%. With a market capitalization of $20.17 billion, this..

Novartis AG (NVS) Stock Analysis: Evaluating the 12.4% Revenue Growth Amidst Market Challenges

Novartis AG (NYSE: NVS), a Swiss pharmaceutical titan, continues to capture investor attention with its robust performance in the healthcare sector, particularly within the drug manufacturing industry. With a commanding..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds